Etoposide with lonidamine or pentoxifyll
โ
Juichi Tanaka; Beverly A. Teicher; Terence S. Herman; Sylvia A. Holden; Bruce De
๐
Article
๐
1991
๐
John Wiley and Sons
๐
French
โ 857 KB
In an effort to improve the additive anti-tumor efficacy of commonly used alkylating agents, the topoisomerase-ll inhibitor etoposide was used in combination with either the mitochondrial poison and energy-depleting agent lonidamine or the hemorheologic agent and tumor-blood-flow-increasing agent pe